🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 22 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/09/2000 50,34 50,34 47,25 47,63 -5,93% 6,15% 22.400
15/09/2000 52,50 52,88 50,25 50,63 -4,26% 5,00% 9.017
14/09/2000 52,50 53,25 50,63 52,88 +3,68% 5,00% 10.317
13/09/2000 51,38 52,13 50,25 51,00 +0,74% 3,65% 7.100
12/09/2000 50,25 52,13 49,50 50,63 +3,05% 5,22% 13.150
11/09/2000 49,50 51,00 49,13 49,13 -0,76% 3,79% 11.350
08/09/2000 51,75 52,50 49,50 49,50 -5,04% 5,80% 14.600
07/09/2000 53,25 53,25 51,00 52,13 -2,11% 4,23% 22.617
06/09/2000 52,88 53,25 52,13 53,25 +0,00% 2,13% 7.417
05/09/2000 53,91 55,13 52,50 53,25 +0,00% 4,87% 22.950
01/09/2000 55,13 55,13 52,50 53,25 -3,40% 4,76% 17.283
31/08/2000 56,06 56,25 51,00 55,13 -0,68% 9,36% 60.033
30/08/2000 57,94 59,63 55,13 55,50 -3,90% 7,77% 38.967
29/08/2000 60,75 61,50 54,75 57,75 -3,75% 11,11% 42.067
28/08/2000 54,09 63,00 54,00 60,00 +14,29% 16,64% 125.733
25/08/2000 48,75 53,25 48,38 52,50 +9,38% 10,00% 64.283
24/08/2000 49,50 50,81 46,88 48,00 -1,54% 7,95% 67.033
23/08/2000 42,94 49,50 42,75 48,75 +14,04% 15,72% 60.000
22/08/2000 42,38 44,25 41,63 42,75 +1,79% 6,19% 28.850
21/08/2000 40,31 42,00 40,13 42,00 +4,67% 4,65% 13.733
18/08/2000 42,00 43,13 39,75 40,13 +0,94% 8,04% 10.817
17/08/2000 41,91 42,38 39,75 39,75 -3,64% 6,26% 15.033
16/08/2000 42,00 43,13 40,50 41,25 +0,00% 6,25% 19.500
15/08/2000 40,88 42,38 40,50 41,25 +0,92% 4,59% 11.950
14/08/2000 41,25 43,13 40,50 40,88 -3,54% 6,36% 10.400
11/08/2000 41,25 42,75 40,88 42,38 +0,89% 4,55% 11.900
10/08/2000 44,06 44,63 40,50 42,00 -2,61% 9,36% 19.500
09/08/2000 43,31 43,88 42,75 43,13 -0,86% 2,60% 7.033
08/08/2000 45,75 46,13 42,75 43,50 -2,93% 7,38% 13.917
07/08/2000 44,81 47,25 44,25 44,81 -0,42% 6,69% 47.533